The Intrauterine Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Intrauterine Devices Market:
https://www.thebusinessresearchcompany.com/report/intrauterine-devices-global-market-report
In accordance with The Business Research Company’s Global Market Report for Intrauterine Devices in 2024, the market has exhibited robust growth in recent years, with a projected increase from $3.75 billion in 2024 to $3.96 billion in 2024, boasting a compound annual growth rate (CAGR) of 5.7%. This surge in the historical period can be ascribed to multifaceted factors including proactive family planning endeavors, the bolstering of women’s autonomy, the adoption of long-acting reversible contraception (LARC), heightened contraceptive efficiency, cost efficiency, diminished side effects, and amplified advocacy from healthcare professionals.
Anticipated is a sustained trajectory of expansion within the intrauterine devices market over the forthcoming years, poised to ascend to $4.74 billion by 2028, portraying a CAGR of 4.6%. The prognosticated surge in the forecast period is underpinned by burgeoning consciousness and enlightenment, global healthcare initiatives, a pivot towards non-hormonal alternatives, the broadening access to healthcare services, tailored contraceptive preferences, the provision of reproductive services geared towards youth, and the assimilation of primary care services. Remarkable trends expected to prevail during this timeframe encompass the advancement of frameless IUDs, breakthroughs in biodegradable variants, refinements in user-friendly insertion mechanisms, the fusion of contraceptive counseling provisions, and the exploration of non-contraceptive health dividends.
Prominent enterprises within the intrauterine devices domain are actively engaged in pioneering endeavors aimed at introducing innovative solutions, exemplified by the development of IUB Ballerine, poised to furnish women with a more efficacious and expedient mode of birth control. IUB Ballerine, a hormone-free, enduringly reversible contraceptive, is fashioned from a pliant nickel/titanium alloy framework adorned with copper beads. These beads gradually dispense copper ions into the uterine cavity, instigating an environment inhospitable to spermatozoa, thus avertting conception. Noteworthy is the debut of the next-generation intrauterine device (IUD) christened IUB Ballerine by Consilient Health Ltd., a UK-based pharmaceutical entity, in December 2022. This pioneering contraceptive alternative proffers manifold advantages vis-a-vis conventional methodologies, characterized by its protracted duration of efficacy, reversibility, and hormone-free composition. Distinguished by its spherical configuration, comfort, and user-friendliness, this innovative IUD boasts a distinct three-dimensional structure comprising copper beads ensconced on a flexible Nitinol framework. Engineered to conform to uterine contours, it mitigates the risk of expulsion and fundal perforation during placement, thus heralding a monumental stride in intrauterine contraception, underscored by heightened safety and simplicity of use.
The intrauterine devices market covered in this report is segmented –
1) By Product: Hormonal Intrauterine Device, Copper Intrauterine Device
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years
3) By End-User: Hospitals, Gynaecology Clinics, Community Healthcare, Other End Users
Top 5 Major Players:
Major companies operating in the intrauterine devices market are developing innovative products such as IUB Ballerine to provide women with a more effective and convenient form of birth control. IUB Ballerine is a hormone-free, long-lasting reversible contraceptive that is made of a flexible nickel/titanium alloy frame with copper beads strung on it. The copper beads release copper ions into the uterus, which creates an environment that is hostile to sperm, preventing pregnancy. For instance, in December 2022, Consilient Health Ltd., a UK-based pharmaceutical company, launched a next-generation intrauterine device (IUD) called IUB Ballerine, a promising new form of birth control that offers several advantages over traditional methods. It is a long-lasting, reversible, and hormone-free option that is designed to be spherical, comfortable, and easy to use. This innovative IUD features a unique three-dimensional ball-like structure composed of copper beads on a flexible Nitinol frame. It is designed to adapt to the uterus, minimizing the risk of expulsion and fundal perforation during insertion. Moreover, it represents a significant advancement in intrauterine contraception, offering improved safety and ease of use.
The intrauterine devices market report table of contents includes:
1. Executive Summary
2. Intrauterine Devices Market Characteristics
3. Intrauterine Devices Market Trends And Strategies
4. Intrauterine Devices Market – Macro Economic Scenario
5. Global Intrauterine Devices Market Size and Growth
32. Global Intrauterine Devices Market Competitive Benchmarking
33. Global Intrauterine Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Intrauterine Devices Market
35. Intrauterine Devices Market Future Outlook and Potential Analysis
36. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Intrauterine Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Intrauterine Devices Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Intrauterine Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
….
Table 74: Cardinal Health Inc. Financial Performance
Table 75: Pfizer Inc. Financial Performance
Table 76: Merck and Co. Inc. Financial Performance
Table 77: AbbVie Inc. Financial Performance
Table 78: Bayer AG Financial Performance
Related Reports:
https://topprnews.com/protein-shampoo-market-share/
https://topprnews.com/protein-supplements-market-share/
https://topprnews.com/psychedelic-drugs-market-report/
https://goodprnews.com/protein-shampoo-market-size/
https://goodprnews.com/protein-supplements-market-size/
https://goodprnews.com/psychedelic-drugs-market-report/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The cytotoxic drugs global market report 2024 from The Business Research Company provides comprehensive market…
The combat management system global market report 2024from The Business Research Company provides comprehensive market…
The clinical trial imaging global market report 2024from The Business Research Company provides comprehensive market…
The cancer supportive care drugs global market report 2024from The Business Research Company provides comprehensive…
The waste management software market size is expected to see strong growth in the next…
The business process documentation tools global market report 2024 from The Business Research Company provides…